Sandostatin® in the Treatment of Gastroenteropancreatic Endocrine Tumors

Consensus Round Table, Scottsdale (Arizona), March 22, 1987

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Endocrinology & Metabolism, Gastroenterology
Cover of the book Sandostatin® in the Treatment of Gastroenteropancreatic Endocrine Tumors by , Springer Berlin Heidelberg
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783642613289
Publisher: Springer Berlin Heidelberg Publication: December 6, 2012
Imprint: Springer Language: English
Author:
ISBN: 9783642613289
Publisher: Springer Berlin Heidelberg
Publication: December 6, 2012
Imprint: Springer
Language: English

The secretion of bioactive products by tumors of the gastroenteropancreatic system results in the development of watery diarrhea that can lead to death in a very short period if not brought under control. Even if the consequences are less dramatic, the patients' ability to lead a normal daily life is seriously impaired, and they may become severely depressed. SandostatinR alleviates the condition by inhibiting peptide release, and its long duration of action makes it an effective and rational adjunct to therapy at all stages. Last year a consensus Round Table Meeting was held in Scottsdale, Arizona, to discuss the optimal use of SandostatinR in this indication. These guidelines offer the results of clinical research and the dosage recommendations arising from them, together with a critical summary of the points of view presented.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

The secretion of bioactive products by tumors of the gastroenteropancreatic system results in the development of watery diarrhea that can lead to death in a very short period if not brought under control. Even if the consequences are less dramatic, the patients' ability to lead a normal daily life is seriously impaired, and they may become severely depressed. SandostatinR alleviates the condition by inhibiting peptide release, and its long duration of action makes it an effective and rational adjunct to therapy at all stages. Last year a consensus Round Table Meeting was held in Scottsdale, Arizona, to discuss the optimal use of SandostatinR in this indication. These guidelines offer the results of clinical research and the dosage recommendations arising from them, together with a critical summary of the points of view presented.

More books from Springer Berlin Heidelberg

Cover of the book New Concepts in Pathology and Treatment of Autoimmune Disorders by
Cover of the book How to Gain Gain by
Cover of the book Genetics of the Epilepsies by
Cover of the book Hypercalcemia of Malignancy by
Cover of the book Semantic Search over the Web by
Cover of the book Protein and Amino Acid Metabolism in Cancer Cachexia by
Cover of the book Learning and Intelligent Optimization by
Cover of the book Geborgenheit: Quelle der Stärke by
Cover of the book Design and Diagnosis for Sustainable Organizations by
Cover of the book Structure-Preserving Algorithms for Oscillatory Differential Equations by
Cover of the book Managed Evolution by
Cover of the book Solarthermie by
Cover of the book Nichtlineare Regelungssysteme by
Cover of the book Spider Ecophysiology by
Cover of the book Globalization and Regional Growth in Europe by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy